What is Therma Bright Inc. (TBRIF)?

Therma Bright Inc. (TBRIF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of TBRIF?

The current price of TBRIF is $0.02. Prices are updated in real time on Stocks360.

What is TBRIF's price-to-earnings (PE) ratio?

TBRIF's trailing twelve-month PE ratio is -0.44, based on current price and earnings per share data available on Stocks360.

What is TBRIF's market capitalization?

TBRIF's market capitalization is $1,347,426.00, placing it in the small-cap tier.

Therma Bright Inc. (TBRIF)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.02

Market Cap

$1.35M

PE (TTM)

-0.44

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.13

Day Range

$0.02 – $0.03

52-wk Range

$0.02 – $0.07

Avg Volume

N/A

Volume

50.00K

Therma Bright Inc. (TBRIF) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $1.35M. Trailing PE -0.44. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 10 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.06 2026-10-30 · $0.02 (-62.71%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Therma Bright Inc.

Based in Toronto, Canada, Therma Bright Inc., established in 2001 and formerly known as The Jenex Corporation until its rebranding in 2018, specializes in the creation and commercialization of a diverse portfolio of medical and consumer health devices. Their offerings include rapid diagnostic tests for COVID-19, such as AcuVid, which screens for both antigens and antibodies. The company also provides innovative solutions for pain management and other health concerns, featuring InterceptCS, a system utilizing controlled topical heat to prevent cold sores, and Benepod, a hot and cold contrast therapy device designed for drug-free pain relief. Furthermore, they offer the Venowave medical compression pump to treat symptoms associated with poor circulation. For insect bites and stings, Therma Bright produces TherOZap, a thermal therapy device that effectively reduces inflammatory responses, itching, and pain. Their products cater to a broad market, serving both general consumers and healthcare professionals.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.44×
P/S (TTM)	13.53×
P/B	-0.95×
PEG	0.00×
P/FCF (TTM)	-8.45×
EV / EBITDA	-0.47×
EV / Sales	13.81×
Earnings Yield	-218.18%
Free Cash Flow Yield	-11.83%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.88M
Revenue (TTM)	$135.82K
Net Income (TTM)	-$4.01M
Free Cash Flow (TTM)	-$217.35K
Net Debt	$38.16K
Working Capital	-$1.97M
Gross Margin	49.03%
Operating Margin	-906.32%
Net Margin	-2951.53%
Return on Equity	234.23%
Return on Invested Capital	65.14%